Published May 31, 2022 | Version v1
Journal article Restricted

Anti-tumor alkaloids from Peganum harmala

  • 1. * & ** & Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, PR China

Description

Zhang, Qin, Zan, Yan-Hui, Yang, Han-Gao, Yang, Meng-Yue, Liu, Fang-Shen, Li, Sheng-Ge, Peng, Xiao-Hui, Lin, Bin, Li, Zhan-Lin, Li, Da-Hong, Hua, Hui-Ming (2022): Anti-tumor alkaloids from Peganum harmala. Phytochemistry (113107) 197: 1-7, DOI: 10.1016/j.phytochem.2022.113107, URL: http://dx.doi.org/10.1016/j.phytochem.2022.113107

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:FF84FFD6FFC9FF88FFF6B95EFFC11961

References

  • Anouhe, J.B.S., Adima, A.A., Niamk´e, F.B., Stien, D., Amian, B.K., Blandini`eres, P.A., Virieux, D., Pirat, J.L., Kati-Coulibaly, S., Amusant, N., 2015. Dicorynamine and harmalan-N-oxide, two new β- carboline alkaloids from Dicorynia guianensis heartwood. Phytochem. Lett. 12, 158-163. https://doi.org/10.1016/j. phytol.2015.03.012.
  • Atta-Ur-Rahman, Sultana, N., Akhter, F., Nighat, F., Choudhary, M.I., 1997. Phytochemical studies on Adhatoda vasica Nees. Nat. Prod. Lett. 10, 249-256. https://doi.org/10.1080/10575639708043737.
  • Banerjee, S., Wang, Z.W., Mohammad, M., Sarkar, F.H., Mohammad, R.M., 2008. Efficacy of selected natural products as therapeutic agents against cancer. J. Nat. Prod. 71, 492-496. https://doi.org/10.1021/np0705716.
  • Cacchi, S., Fabrizi, G., Marinelli, F., Moro, L., Pace, P., 1996. Palladium-catalysed hydroarylation and hydrovinylation of 3,3-dialkoxy-1-aryl-1-propynes. An approach to 3-aryl- and 3-vinylquinolines. Tetrahedron 52, 10225-10240. https://doi.org/ 10.1016/0040-4020(96)00557-1.
  • Corbally, R.P., Mehta, L.K., Parrick, J., Short, E.L., 2000. Experimental and calculated 13C chemical shifts for α-, β-, γ- and δ- carbolines. Magn. Reson. Chem. 38, 1034-1036. https://doi.org/10.1002/1097-458X(200012)38:12<1034::AID- MRC783>3.0.CO;2-M.
  • Dassonneville, B., Witulski, B., Detert, H., 2011. Cycloadditions of alkynylynamides-a total synthesis of perlolyrine and the first total synthesis of "Isoperlolyrine". Eur. J. Org Chem. 15, 2836-2844. https://doi.org/10.1002/ejoc.201100121.
  • Fatma, B., Fatiha, M., Elattafia, B., Noureddine, D., 2016. Phytochemical and antimicrobial study of the seeds and leaves of Peganum harmala L. against urinary tract infection pathogens. Asian Pac. J. Trop. Dis. 6, 822-826. https://doi.org/ 10.1016/S2222-1808(16)61139-8.
  • Gezici, S., Sekeroglu ˘, N., 2019. Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anti Cancer Agents Med. Chem. 19, 101-111. https://doi.org/10.2174/1871520619666181224121004.
  • Gou, L.L., Lee, Y.G.G., Tenzin, P.P., San, L.C.B., 2020. A review on the relationship of mast cells and macrophages in breast cancer-can herbs or natural products facilitate their anti-tumor effects? Pharmacol. Res. 164, 105321. https://doi.org/ 10.1016/J.PHRS.2020.105321.
  • Huang, M., Lu, J.J., Ding, J., 2021. Natural products in cancer therapy: past, present and future. Nat. Prod. Bioprosp. 11, 5-13. https://doi.org/10.1007/S13659-020-00293- 7.
  • Jalali, A., Dabaghian, F., Zarshenas, M.M., 2021. Alkaloids of Peganum harmala: anticancer biomarkers with promising outcomes. Curr. Pharmaceut. Des. 27, 185-196. https://doi.org/10.2174/1381612826666201125103941.
  • Joshi, B.S., Bai, Y., Puar, M.S., Dubose, K.K., Pelletier, S.W., 1994. 1H- and 13C-NMR assignments for some pyrrolo[2,1b]quinazoline alkaloids of Adhatoda vasica. J. Nat. Prod. 57, 953-962. https://doi.org/10.1021/np50109a012.
  • Joshi, G., Wani, A.A., Sharma, S., Bhutani, P., Bharatam, P.V., Paul, A.T., Kumar, R., 2018. Unanticipated cleavage of 2-nitrophenyl-substituted N-formyl pyrazolines under Bechamp conditions: unveiling the synthesis of 2-aryl quinolines and their mechanistic exploration via DFT studies. ACS Omega 3, 18783-18790. https://doi. org/10.1021/acsomega.8b02682.
  • Li, K., Fu, X.B., Zhao, Y.N., Gao, W.T., Li, Y., 2016. A facile synthesis of novel pyrrolo [3,4-b]quinolin-1-one derivatives. Res. Chem. Intermed. 42, 4273-4287. https://doi. org/10.1007/s11164-015-2273-1.
  • Li, S.G., Wang, Y.T., Zhang, Q., Wang, K.B., X, J.J., Li, D.H., Jing, Y.K., Lin, B., Hua, H.M., 2020. Pegaharmols A-B, axially chiral β- carboline-quinazoline dimers from the roots of Peganum harmala. Org. Lett. 22, 7522-7525. https://doi.org/10.1021/acs. orglett.0c02709.
  • Li, S.P., Cheng, X.M., Wang, C.H., 2017. A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. J. Ethnopharmacol. 203, 127-162. https://doi.org/10.1016/j.jep.2017.03.049.
  • Liu, J.M., Li, Q., Liu, Z.L., Lin, L.M., Zhang, X.Q., Cao, M.R., Jiang, J.W., 2016. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways. Oncol. Rep. 35, 3363-3370. https://doi.org/10.3892/or.2016.4695.
  • Lu, J.J., Wang, Y.T., 2020. Identification of anti-cancer compounds from natural products. Chin. J. Nat. Med. 18, 481-482. https://doi.org/10.1016/S1875-5364(20) 30057-1.
  • Ma, J., Wang, X.L., 1998. The species and distribution of genus Peganum L. in the desert area of China [J]. J. Desert Res. 18, 131-136. CNKI:SUN:ZGSS.0.1998-02-005.
  • Ma, Z.Z., Hano, Y., Nomura, T., Chen, Y.J., 1999. Two new quinazoline-quinoline alkaloids from Peganum nigellastrum. Heterocycles 51, 1883-1889. https://doi.org/ 10.3987/COM-99-8595.
  • Ma, Z.Z., Hano, Y., Nomura, T., Chen, Y.J., 2004. Novel quinazoline-quinoline alkaloids with cytotoxic and DNA topoisomerase II inhibitory activities. Bioorg. Med. Chem. Lett 14, 1193-1196. https://doi.org/10.1016/j.bmcl.2003.12.048.
  • Miraj, S., 2016. A review study of therapeutic effects of Peganum harmala. Der. Pharm. Lett. 8, 161-166. http://scholarsresearchlibrary.com/archive.html.
  • Mondal, A., Gandhi, A., Fimognari, C., Atanasov, A.G., Bishayee, A., 2019. Alkaloids for cancer prevention and therapy: current progress and future perspectives. Eur. J. Pharmacol. 858, 172472. https://doi.org/10.1016/j.ejphar.2019.172472.
  • Plugar, V.N., Abdullaev, N.D., Rashkes, Y.V., Yagudaev, M.R., Tulyaganov, N., 1983. Structure of the products of the metabolism of deoxypeganine and of deoxyvasicinone. Chem. Nat. Compd. 19, 720-727. https://doi.org/10.1007/ BF00575179.
  • Wang, C.H., Zhang, Z.X., Wang, Y.H., He, X.J., 2015. Cytotoxic indole alkaloids against human leukemia cell lines from the toxic plant Peganum harmala. Toxins 7, 4507-4518. https://doi.org/10.3390/toxins7114507.
  • Wang, K.B., Li, D.H., Hu, P., Wang, W.J., Lin, C., Wang, J., Lin, B., Bai, J., Pei, Y.H., Jing, Y.K., Li, Z.L., Yang, D.Z., Hua, H.M., 2016. A series of β- carboline alkaloids from the seeds of Peganum harmala show G-quadruplex interactions. Org. Lett. 18, 3398-3401. https://doi.org/10.1021/acs.orglett.6b01560.
  • Wang, K.B., Li, S.G., Huang, X.Y., Li, D.H., Li, Z.L., Hua, H.M., 2017. (± )-Peharmaline A: a pair of rare β- carboline-vasicinone hybrid alkaloid enantiomers from Peganum harmala. Eur. J. Org Chem. 14, 1876-1879. https://doi.org/10.1002/ ejoc.201700137.
  • Wang, M.L., Niu, J.L., Gao, Y., Wang, Y.P., Zhang, L.F., Zhang, Y., Wang, P., 2018. Effects of harmine on the proliferation, migration and invasion of human breast cancer MCF7 cells. J. Chin. Mater. Med. 7, 1702-1706. https://doi.org/10.13863/j. issn1001-4454.2018.07.039.
  • Wang, X., Geng, Y.L., Wang, D.J., Shi, X.A., Liu, J.H., 2008. Separation and purification of harmine and harmaline from Peganum harmala using pH-zone-refining countercurrent chromatography. J. Separ. Sci. 31, 3543-3547. https://doi.org/10.1002/ jssc.200800322.
  • Xu, X.D., Hu, X.R., Yang, J.S., 2008. Review of studies on active components of antitumor medicinal plants. China J. Chin. Mater. Med. 33, 2073-2081.
  • Yang, Y.D., Cheng, X.M., Liu, W., Chou, G.X., Wang, Z.T., Wang, C.H., 2015. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn. by a bioassayguided fractionation. J. Ethnopharmacol. 168, 279-286. https://doi.org/10.1016/j. jep.2015.03.070.
  • Zhao, T., He, Y.Q., Wang, J., Wang, Z.T., Ding, K.M., Wang, C.H., 2011a. Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by β- carboline alkaloids, harmine derivatives. Phytother Res. 25, 1671-1677. https://doi.org/10.1002/ptr.3458.
  • Zhao, T., Wang, C.H., Wang, Z.T., 2010. Chemical constituents and pharmacologic actions of genus Peganum: research advances. J. Int. Med. Res. 37 https://doi.org/ 10.13220/j.cnki.jipr.2010.05.004, 2010 333-339+ 345.
  • Zhao, T., Wang, Z.T., Branford-White, C.J., Xu, H., Wang, C.H., 2011b. Classification and differentiation of the genus Peganum indigenous to China based on chloroplast trnL- F and psbA-trnH sequences and seed coat morphology. Plant Biol. 13, 940-947. https://doi.org/10.1111/j.1438-8677.2011.00455.x.